Learning Objectives:
- To describe the effect of APOE genotype on risk for Alzheimer’s disease;
- To describe the effect of APOE and TREM2 on amyloid related pathologies;
- To describe the effect of APOE and TREM2 on tau pathology and tau-mediated neurodegeneration
Session date:
03/18/2021 - 7:30am to 8:30am CDT
Location:
Zoom
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dr. David Holtzman, MD